These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38460908)

  • 21. ROR1-AS1 knockdown inhibits growth and invasion and promotes apoptosis in NSCLC cells by suppression of the PI3K/Akt/mTOR pathway.
    Li F; Gu F; Li Q; Zhai C; Gong R; Zhu X
    J Biochem Mol Toxicol; 2021 May; 35(5):e22726. PubMed ID: 33491326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhao L; Zhang J; Fan Y; Li Y
    Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway.
    Zheng R; Jiang H; Li J; Liu X; Xu H
    Curr Cancer Drug Targets; 2017; 17(4):376-385. PubMed ID: 28093061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin potentiates the galbanic acid-induced anti-tumor effect in non-small cell lung cancer cells through inhibiting Akt/mTOR signaling pathway.
    Zhang Q; Qiao H; Wu D; Lu H; Liu L; Sang X; Li D; Zhou Y
    Life Sci; 2019 Dec; 239():117044. PubMed ID: 31715187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihelminthic Niclosamide Induces Autophagy and Delayed Apoptosis in Human Non-small Lung Cancer Cells
    Chai WH; Li YR; Lin SH; Chao YH; Chen CH; Chan PC; Lin CH
    Anticancer Res; 2020 Mar; 40(3):1405-1417. PubMed ID: 32132037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
    Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
    Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Thongsom S; Racha S; Ei ZZ; Petsri K; Aksorn N; Chamni S; Panpuang V; Zou H; Chanvorachote P
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhang W; Shao X
    Med Sci Monit; 2016 Nov; 22():4644-4650. PubMed ID: 27897153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathway.
    Mi S; Xiang G; Yuwen D; Gao J; Guo W; Wu X; Wu X; Sun Y; Su Y; Shen Y; Xu Q
    Toxicol Appl Pharmacol; 2016 Nov; 310():78-86. PubMed ID: 27639426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (+)-Cyanidan-3-ol inhibits epidermoid squamous cell carcinoma growth via inhibiting AKT/mTOR signaling through modulating CIP2A-PP2A axis.
    Monga J; Suthar SK; Rohila D; Joseph A; Chauhan CS; Sharma M
    Phytomedicine; 2022 Jul; 101():154116. PubMed ID: 35525235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plac8-mediated autophagy regulates nasopharyngeal carcinoma cell function via AKT/mTOR pathway.
    Huang ML; Qi CL; Zou Y; Yang R; Jiang Y; Sheng JF; Kong YG; Tao ZZ; Chen SM
    J Cell Mol Med; 2020 Jul; 24(14):7778-7788. PubMed ID: 32468683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isogambogenic acid induces apoptosis-independent autophagic cell death in human non-small-cell lung carcinoma cells.
    Yang J; Zhou Y; Cheng X; Fan Y; He S; Li S; Ye H; Xie C; Wu W; Li C; Pei H; Li L; Wei Z; Peng A; Wei Y; Li W; Chen L
    Sci Rep; 2015 Jan; 5():7697. PubMed ID: 25571970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition.
    Feng FF; Cheng P; Sun C; Wang H; Wang W
    Chin J Nat Med; 2019 Oct; 17(10):768-777. PubMed ID: 31703757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway.
    Zou L; Li X; Lin J; Fang X; Lin J; Zhang L; Zhang Y; Liang Y; Ren J; Liu Y; Huang Z
    J Pharm Pharmacol; 2024 Mar; 76(3):269-282. PubMed ID: 38241189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells.
    Li H; Hu J; Wu S; Wang L; Cao X; Zhang X; Dai B; Cao M; Shao R; Zhang R; Majidi M; Ji L; Heymach JV; Wang M; Pan S; Minna J; Mehran RJ; Swisher SG; Roth JA; Fang B
    Oncotarget; 2016 Jan; 7(3):3548-58. PubMed ID: 26657290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Flavonoid Kushenol Z from
    Chen H; Yang J; Hao J; Lv Y; Chen L; Lin Q; Yuan J; Yang X
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31817093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.